西部黃金(601069.SH):第二大股東楊生榮擬增持1億元-2億元股份
格隆匯11月14日丨西部黃金(601069.SH)公佈,公司於2024年11月14日收到第二大股東楊生榮先生的《首次增持股份吿知函》,楊生榮先生擬通過上海證券交易所允許的方式(包括但不限於集中競價交易、大宗交易等)增持公司A股股份。總體增持金額不低於1億元人民幣(含本數),但不高於2億元人民幣(含本數)。本次增持計劃的實施期限為6個月,以楊生榮先生增持股份首日為起始日。其於2024年11月14日以自有資金通過上海證券交易所交易系統以集中競價方式增持西部黃金A股股份共計3,200,000股,增持金額為39,734,514.00元,佔公司總股本的0.35%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.